King Faisal Hospital has successfully carried out Rwanda’s first percutaneous closure of a patent foramen ovale (PFO), a rare catheter-based heart procedure performed on a stroke patient. The procedure happened on Friday, May 16, and was led by Dr Hugues Lucron, a visiting cardiologist from Switzerland, alongside Rwandan specialist Dr Gérard Misago. ALSO READ: How minimally invasive heart surgeries are saving children’s lives in Rwanda “We are deeply grateful to Occlutech Europe and all our partners for their vital support in making this national milestone possible,” the hospital said in a Monday post on X. “It marks a proud step forward in advancing innovation, expertise and excellence in cardiovascular care in Rwanda.” ALSO READ: Guide to a healthy heart: Understanding Coronary Artery Disease A PFO is a small flap-like hole between the heart’s upper chambers that usually closes at birth. When it stays open, it can allow blood clots to pass from the right to the left side of the heart and potentially trigger a stroke. In most people, it causes no issues. But in some cases, especially patients with cryptogenic strokes, low blood oxygen or a history of blood clots, doctors may recommend its closure. Using a catheter inserted through a vein, the medical team deploys a closure device made of a nickel-titanium alloy that effectively plugs the hole. Over time, heart tissue grows around the device, permanently sealing the opening. Experts say, PFO closures are typically considered for stroke survivors under age 60, especially those who have had multiple unexplained strokes. The procedure also offers an option for patients who cannot take long-term blood thinners. The device remains in the heart for life. Most patients return home within a day or two after the operation and resume normal activities shortly after.
